Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 2Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 3NET 2Gastrointestinal 2Endocrine 2CNS 2Thoracic 1Head & Neck 1

Conditions

Carcinoma, Non-Small-Cell Lung 1053Lung Neoplasms 809Small Cell Lung Carcinoma 192Breast Neoplasms 161Colorectal Neoplasms 159Neoplasms 126Melanoma 118Ovarian Neoplasms 114Pancreatic Neoplasms 111Stomach Neoplasms 99Neoplasm Metastasis 88Esophageal Neoplasms 77Squamous Cell Carcinoma of Head and Neck 76Prostatic Neoplasms 69Uterine Cervical Neoplasms 66Head and Neck Neoplasms 65Endometrial Neoplasms 64Triple Negative Breast Neoplasms 61Carcinoma, Renal Cell 58Colonic Neoplasms 57Urinary Bladder Neoplasms 49Mesothelioma, Malignant 49Adenocarcinoma of Lung 49Carcinoma, Hepatocellular 46Mesothelioma 43Sarcoma 41Brain Neoplasms 40Liver Neoplasms 39NSCLC 33Kidney Neoplasms 33

Interventions

repotrectinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Neuroectodermal Tumors × Thoracic × Clear all
NCT03093116 2026-05-27

TRIDENT-1

Turning Point Therapeutics, Inc.

Phase 1/2 Recruiting
500 enrolled 2 FDA
EndocrineGastrointestinalHead & NeckNETSarcomaThoracic

Adenocarcinoma, Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Colonic Diseases, Colonic Neoplasms, Digestive System Neoplasms, Endocrine System Diseases, Endocrine Gland Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Intestinal Diseases, Intestinal Neoplasms, Lung Diseases, Lung Neoplasms, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Respiratory Tract Diseases, Respiratory Tract Neoplasms, Sarcoma, Thoracic Neoplasms, Thyroid Diseases, Thyroid Neoplasms, Neuroectodermal Tumors, Carcinoma, Neuroendocrine, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡